ArticleScientific reports2025
Diabetic retinopathy detection using adaptive deep convolutional neural networks on fundus images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A hybrid CNN-GNN and multitask learning pipeline for improving mild diabetic retinopathy sensitivity.MethodsX · 2026Article
- A Text-Guided Lesion Mining Vision-Language Ordinal Classification Framework for Diabetic Retinopathy Grading.Journal of imaging · 2026Article
- A systematic review on deep learning techniques for diabetic retinopathy classification in retinal fundus images.iScience · 2026Article
- A gated task-attentive multi-task network for unified retinal image analysis.Scientific reports · 2026Article
- Glycosylation gene-based molecular recognition model for diabetic retinopathy.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) is an age-related macular degeneration eye disease problem that causes pathological changes in the retinal neural and vascular system. Recently, fundus imaging is a popular technology and widely used for clinical diagnosis, diabetic retinopathy, etc. It is evident from the literature that image quality changes due to uneven illumination, pigmentation level effect, and camera sensitivity affect clinical performance, particularly in automated image analysis systems. In addition, low-quality retinal images make the subsequent precise segmentation a challenging task for the computer diagnosis of retinal images. Thus, in order to solve this issue, herein, we proposed an adaptive enhancement-based Deep Convolutional Neural Network (DCNN) model for diabetic retinopathy (DR). In our proposed model, we used an adaptive gamma enhancement matrix to optimize the color channels and contrast standardization used in images. The proposed model integrates quantile-based histogram equalization to expand the perceptibility of the fundus image. Our proposed model provides a remarkable improvement in fundus color images and can be used particularly for low-contrast quality images. We performed several experiments, and the efficiency is evaluated using a large public dataset named Messidor's. Our proposed model efficiently classifies a distinct group of retinal images. The average assessment score for the original and enhanced images is 0.1942 (standard deviation: 0.0799), Peak Signal-to-Noise Ratio (PSNR) 28.79, and Structural Similarity Index (SSIM) 0.71. The best classification accuracy is [Formula: see text], indicating that Convolutional Neural Networks (CNNs) and transfer learning are superior to traditional methods. The results show that the proposed model increases the contrast of a particular color image without altering its structural information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.